Thrombectomy in deep vein thrombosis: a definitive treatment
Keywords:DVT, Pulmonary embolism, Venous thromboembolism, Thrombectomy
Background: The development of blood clots (thrombi) in the deep veins is known as deep vein thrombosis (DVT). It frequently affects the deep pelvic veins or the deep leg veins (such as the calf veins, femoral vein, or popliteal vein). It is a potentially fatal condition that may result in morbidity and mortality that can be prevented. Aim was to assess the effectiveness of thrombectomy in treating patients with DVT.
Methods: The 196 patients with DVT reporting to VKP’s VJ hospital, Tirunelveli, Tamil Nadu, were selected for this retrospective study. Thrombectomy was chosen as the treatment modality in this study.
Results: Most patients were in the age group between 41 to 60 years (59.5%), with male predominance noted (77.4%). Pain and swelling are the most typical clinical features, 64.6% of patients presented with this sign. In patients with chronic and sub-acute DVT, 25% and 10.2% had residual thrombus visualized in doppler. Late complication, varicose veins were seen higher in patients with common iliac vein thrombosis (2/3) 66.7%, 52.6% (10/19) in external iliac vein thrombosis and 34.8% (8/23) in popliteal vein thrombosis. Late complication recurrence was seen higher in patients with partial occlusion (5/14) 35.7%, 21.4% (3/14) had varicose veins.
Conclusions: The best course of treatment for DVT patients is thrombectomy, which can restore venous patency, stop DVT from returning, alleviate PTS, and prevent pulmonary embolism.
Cronan JJ, Dorfman GS, Grusmark J. Lower-extremity deep venous thrombosis: further experience with and refinements of US assessment. Radiology. 1988;168(1):101-7.
Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am. 1984;66(2):194-201.
Lee LH, Gu KQ, Heng D. Deep vein thrombosis is not rare in Asia-The Singapore General Hospital experience. Ann Acad Med Singapore. 2002;31:761-4.
Agarwala S, Bhagwat AS, Modhe J. Deep vein thrombosis in Indian patients undergoing major lower limb surgery. Indian J Surg. 2003;65:159-62.
Agarwala S, Bhagwat AS, Wadhwani R. Pre and post operative DVT in Indian patients-Efficacy of LMWH as a prophylaxis agent. Ind J Orth. 2005;39:55-8.
Watz R, Savidge GF. Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis: a comparative study between streptokinase and heparin therapy. Acta Medica Scandinavica. 1979;205(1‐6):293-8.
Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2004;(4):CD002783.
Alesh I, Kayali F, Stein PD. Catheter‐directed thrombolysis (intrathrombus injection) in treatment of deep venous thrombosis: A systematic review. Catheterization Cardiovasc Interventions. 2007;70(1):145-50.
Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL et al. Society for Vascular Surgery; American Venous Forum. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2012;55(5):1449-62.
Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Internal Med. 1995;155(10):1031-7.
Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. Journal of vascular surgery. 2000;32(1):130-7.
Mewissen MW. Catheter-directed thrombolysis for lower extremity deep vein thrombosis. Techniques Vascu Interventional Radiol. 2001;4(2):111-4.
Meissner MH. Thrombolytic therapy for acute deep vein thrombosis and the venous registry. Rev Cardiovasc Med. 2002;3(S2):53-60.
Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz Jr CA, Caldwell MD et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vascular Interventional Radiol. 1997;8(3):405-18.
Huang CY, Hsu HL, Kuo TT, Lee CY, Hsu CP. Percutaneous pharmacomechanical thrombectomy offers lower risk of post-thrombotic syndrome than catheter-directed thrombolysis in patients with acute deep vein thrombosis of the lower limb. Ann Vascular Surg. 2015;29(5):995-1002.
Van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;626-33.
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;8-27.
Patterson BO, Hinchliffe R, Loftus IM, Thompson MM, Holt PJ. Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis. Arteriosclerosis Thrombosis Vascular Biol. 2010;30(4):669-74.
Popuri RK, Vedantham S. The role of thrombolysis in the clinical management of deep vein thrombosis. Arteriosclerosis, thrombosis, and vascular biology. 2011;31(3):479-84.
Karthikesalingam A, Young EL, Hinchliffe RJ, Loftus IM, Thompson MM, Holt PJ. A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Euro J Vascular Endovascular Surg. 2011;41(4):554-65.
White RH, Zhou H, Romano PS. Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Internal Med. 1998;158(9):1005-10.